{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:28:21Z","timestamp":1780579701153,"version":"3.54.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1997,2,1]],"date-time":"1997-02-01T00:00:00Z","timestamp":854755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[1997,2]]},"DOI":"10.1016\/s0924-977x(96)00042-9","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T17:51:32Z","timestamp":1027619492000},"page":"25-38","source":"Crossref","is-referenced-by-count":363,"title":["Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)"],"prefix":"10.1016","volume":"7","author":[{"given":"F.X.","family":"Vollenweider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.L.","family":"Leenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"\u00d8ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Angst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0924-977X(96)00042-9_BIB1","doi-asserted-by":"crossref","unstructured":"Anis, N.A., Berry, S.C., Burton, N.R. and Lodge, D. (1983) The dissociative anesthetics, ketamine and phencyclidine selective reduce excitation of central mammalian neurons by N-methyl-d-aspartate. Br. J. Pharmacol. 79, 565\u2013575.","DOI":"10.1111\/j.1476-5381.1983.tb11031.x"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB2","unstructured":"Arbeitsgemeinschaft f\u00fcr Methodik und Dokumentation in der Psychiatrie AMDP (1981) Das AMDP-System. Manual zur Dokumentation psychiatrischer Befunde. Springer-Verlag, Berlin."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB3","doi-asserted-by":"crossref","unstructured":"Bowers, M.B. (1968) Pathogenesis of acute schizophrenic psychosis. Arch. Gen. Psychiatry 15, 240\u2013248.","DOI":"10.1001\/archpsyc.1966.01730150016003"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB4","doi-asserted-by":"crossref","unstructured":"Bowers, M.B. and Freedman, D.X. (1966) `Psychedelic' experiences in acute psychoses. Arch. Gen. Psychiatry 15, 240\u2013248.","DOI":"10.1001\/archpsyc.1966.01730150016003"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB5","doi-asserted-by":"crossref","unstructured":"Buchsbaum, M.S., Nuechterlein, K.H., Haier, R.J., Wu, J., Sicotte, N., Hazlett, E., Asarnow, R., Potkin, S. and Guich, S. (1990) Glucose metabolic rate in normals and schizophrenics during the continuous performance test assessed by positron emission tomography. Br. J. Psychiatry 156, 216\u2013227.","DOI":"10.1192\/bjp.156.2.216"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB6","doi-asserted-by":"crossref","unstructured":"Carlsson, M. and Carlsson, A. (1990) Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophr. Bull. 16, 425\u2013432.","DOI":"10.1093\/schbul\/16.3.425"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB7","doi-asserted-by":"crossref","unstructured":"Chapman, J. (1966) The early symptoms of schizophrenia. Br. J. Psychiatry 112, 225\u2013251.","DOI":"10.1192\/bjp.112.484.225"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB8","doi-asserted-by":"crossref","unstructured":"Cleghorn, J.M., Garnett, E.S., Nahmias, C., Firnau, G., Brown, G.M., Kaplan, R., Szechtman, H. and Szechtman, B. (1989) Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psychiatry Res. 28, 119\u2013133.","DOI":"10.1016\/0165-1781(89)90040-1"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB9","doi-asserted-by":"crossref","unstructured":"Collier, B.B. (1972) Ketamine and the conscious mind. Anaesthesia 27, 120\u2013137.","DOI":"10.1111\/j.1365-2044.1972.tb08186.x"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB10","doi-asserted-by":"crossref","unstructured":"Corssen, G., Miyasaka, M. and Domino, E.F. (1968) Changing concepts in pain control during surgery: dissociative anesthesia with CI-581. A progress report. Anesth. Analg. 47, 745\u2013759.","DOI":"10.1213\/00000539-196811000-00022"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB11","doi-asserted-by":"crossref","unstructured":"de Wit, H., Metz, J., Wagner, N. and Cooper, M. (1990) Behavioral and subjective effects of ethanol: relationship to cerebral metabolism using PET. Alcohol Clin. Exp. Res. 14, 482\u2013489.","DOI":"10.1111\/j.1530-0277.1990.tb00508.x"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB12","unstructured":"de Wit, H., Metz, J. and Cooper, M. (1991) Effects of ethanol, diazepam and amphetamines on cerebral metabolic rate: PET studies using FDG. NIDA Res. Monogr. 105, 61\u201367."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB13","doi-asserted-by":"crossref","unstructured":"Deakin, J.F.W., Slater, P., Simpson, M.D.C., Gilchrist, A.C., Skan, W.J., Royston, M.C., Reynolds, G.P. and Cross, A.J. (1989) Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J. Neurochem. 52, 1781\u20131786.","DOI":"10.1111\/j.1471-4159.1989.tb07257.x"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB14","unstructured":"Debonnel, G. (1993) Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry. J. Psychiatry Neurosci. 18, 157\u2013172."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB15","unstructured":"Dittrich, A. (1985) \u00c4tiologie-unabh\u00e4ngige Strukturen ver\u00e4nderter Wachbewusstseinszust\u00e4nde. Ferdinand Enke Verlag, Stuttgart."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB16","unstructured":"Dittrich, A. (1994) Psychological aspects of altered states of consciousness of the LSD type: measurements of their basic dimensions and prediction of individuall differences. In: Pletscher, A. and Ladewig, D. (Eds.), 50 Years of LSD. Current Status and Perspectives of Hallucinogens. Parthenon Publishing, New York, pp. 101\u2013118."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB17","unstructured":"Dittrich, A., von Arx, S. and Staub, S. (1981) International study on altered states of consciousness (ISASC). Schweiz. Z. Psychol. und Anw. 40, 189\u2013200."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB18","unstructured":"Dittrich, A., von Arx, S. and Staub, S. (1985) International study on altered states of consciousness (ISASC). Summary of the results. Germ. J. Psychol. 9, 319\u2013339."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB19","doi-asserted-by":"crossref","unstructured":"Domino, E.F., Chodoff, P. and Corssen, S. (1965) Pharmacological effects of Cl-581, a new dissociative anesthetic in man. Clin. Pharmacol. Ther. 6, 279\u2013291.","DOI":"10.1002\/cpt196563279"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB20","doi-asserted-by":"crossref","unstructured":"Ebmeier, K.P., Blackwood, D.H.R., Murray, C., Souza, V., Walker, M., Doughall, N., Moffoot, A.P.R., O'Carroll, R.E. and Goodwin, G.M. (1993) Single-photon emission computed tomography with 99 mTc-Exametazime in unmedicated schizophrenic patients. Biol. Psychiatry 33, 487\u2013495.","DOI":"10.1016\/0006-3223(93)90002-U"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB21","unstructured":"Fahrenberg, J., Hampel, R. and Selg, H. (1984) Das Freiburger Pers\u00f6nlichkeitsinventar FPI. Hogrefe, G\u00f6ttingen."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB22","doi-asserted-by":"crossref","unstructured":"Feng, N., Vollenweider, F.X., Minder, E.I., Rentsch, K., Grampp, T. and Vonderschmitt, D.J. (1995) Development of a gas chromatography-mass spectrometry method for determination of ketamine in plasma and its application to human samples. Ther. Drug Monit. 17, 95\u2013100.","DOI":"10.1097\/00007691-199502000-00016"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB23","doi-asserted-by":"crossref","unstructured":"Freedman, B. and Chapman, L.J. (1973) Early subjective experiences in schizophrenic episodes. J. Abnorm. Psychol. 82, 46\u201354.","DOI":"10.1037\/h0034952"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB24","doi-asserted-by":"crossref","unstructured":"Friston, K.J., Passingham, R.E., Nutt, J.G., Heather, J.D., Sawle, G.V. and Frackowiak, R.S. (1989) Localisation in PET images: direct fitting of the intercommissural (AC-PC) line. J. Cereb. Blood Flow Metab. 9, 690\u2013695.","DOI":"10.1038\/jcbfm.1989.97"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB25","doi-asserted-by":"crossref","unstructured":"Friston, K.J., Frith, C.D., Liddle, P.F. and Frackowiak, R.S. (1991) Plastic transformation of PET images. J. Comput. Assist. Tomogr. 15, 634\u2013639.","DOI":"10.1097\/00004728-199107000-00020"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB26","doi-asserted-by":"crossref","unstructured":"Ghoneim, M.M., Hinrichs, J.V., Mewaldt, S.P. and Petersen, R.C. (1985) Ketamine: behavioral effects of subanesthetic doses. J. Clin. Psychopharmacol. 5, 70\u201377.","DOI":"10.1097\/00004714-198504000-00003"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB27","unstructured":"Gouzoulis, E., Hermle, L. and Sass, H. (1994) Psychedelische Erlebnisse zu Beginn produktiver Episoden endogener Psychosen. Nervenarzt. 65, 198\u2013201."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB28","doi-asserted-by":"crossref","unstructured":"Hammer, R.P.J., Herkenham, M., Pert, C.B. and Quirion, R. (1982) Correlation of regional brain metabolism with receptor localization during ketamine anesthesia: combined autoradiographic 2-[3H]deoxy-d-glucose receptor binding technique. Proc. Natl. Acad. Sci. USA 79, 3067\u20133070.","DOI":"10.1073\/pnas.79.9.3067"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB29","doi-asserted-by":"crossref","unstructured":"Hansen, G., Jensen, S.B., Chandresh, L. and Hilden, T. (1989) The psychotropic effect of ketamine. J. Psychoactive Drugs 20, 419\u2013425.","DOI":"10.1080\/02791072.1988.10472511"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB30","doi-asserted-by":"crossref","unstructured":"Hermle, L., Spitzer, M., Borchardt, D. and Gouzoulis, E. (1992) Beziehungen der Modell-bzw. Drogenpsychosen zu schizophrenen Erkrankungen. Fortschr. Neurol. Psychiat. 60, 383\u2013392.","DOI":"10.1055\/s-2007-1000662"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB31","doi-asserted-by":"crossref","unstructured":"Ishimaru, M., Kurumaji, A. and Toru, M. (1994) Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis. Biol. Psychiatry 35, 84\u201395.","DOI":"10.1016\/0006-3223(94)91197-5"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB32","unstructured":"Janke, W. and Debus, G. (1978) Die Eigenschaftsw\u00f6rterliste (EWL-K)-Ein Verfahren zur Erfassung der Befindlichkeit. Hogrefe, G\u00f6ttingen."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB33","doi-asserted-by":"crossref","unstructured":"Kaplan, R.D., Szechtman, H., Franco, S., Szechtman, B., Nahmias, C., Garnett, E.S., List, S. and Cleghorn, J.M. (1993) Three clinical syndromes of schizophrenia in untreated subjects: relation to glucose activity measured by positron emission tomography (PET). Schizophr. Res. 11, 47\u201354.","DOI":"10.1016\/0920-9964(93)90037-J"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB34","doi-asserted-by":"crossref","unstructured":"Kim, J.S., Kornhuber, H.H., Schmid-Burke, W. and Holzm\u00fcller, B. (1980) Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett. 20, 379\u2013382.","DOI":"10.1016\/0304-3940(80)90178-0"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB35","doi-asserted-by":"crossref","unstructured":"Kornhuber, J., Mack-Burkhardt, F., Riederer, P., Hebenstreit, G.F., Reynolds, G.P., Andrews, H.B. and Beckmann, H. (1989) [3H]MK-801 binding sites in postmortem brain regions of schizophrenic patiens. J. Neuronal Transm. 77, 231\u2013236.","DOI":"10.1007\/BF01248936"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB36","doi-asserted-by":"crossref","unstructured":"Krystal, J.H., Karper, L.P., Seibyl, J.P., Freeman, G.F., Delaney, R., Bremner, J.D., Heiniger, R., Bowers, M.B. and Charney, D.S. (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Arch. Gen. Psychiatry 51, 199\u2013214.","DOI":"10.1001\/archpsyc.1994.03950030035004"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB37","doi-asserted-by":"crossref","unstructured":"Lahti, A.C., Holcomb, H.H., Medoff, D.R. and Tamminga, C.A. (1995) Ketamine activates psychosis and alters limbic blood flow in schizophrenia. NeuroReport 6, 869\u2013872.","DOI":"10.1097\/00001756-199504190-00011"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB38","doi-asserted-by":"crossref","unstructured":"Liddle, P.F., Friston, K.J., Frith, C.D., Hirsch, S.R. and Frackowiak, R.S.J. (1992) Patterns of cerebral blood flow in schizophrenia. Br. J. Psychiatry 160, 179\u2013186.","DOI":"10.1192\/bjp.160.2.179"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB39","unstructured":"London, E.D., Dam, M. and Weissman, A.D. (1988) Different patterns of cerebral glucose utilization produced by phencyclidine and d-N-allylnormetazocinel. In: Domino, E.F. and Kamenka, J.M. (Eds.), Sigma and phencyclidine-like compounds as molecular probes in biology. NPP Books, Michigan, pp. 297\u2013326."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB40","doi-asserted-by":"crossref","unstructured":"Luby, E.D., Cohen, B.D., Rosenbaum, G., Gottlieb, J.S. and Kelley, R. (1959) Study of a new schizophrenomimetic drug, Sernyl. Arch. Neurol. Psychiatry 81, 363\u2013369.","DOI":"10.1001\/archneurpsyc.1959.02340150095011"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB41","doi-asserted-by":"crossref","unstructured":"Mathisen, L.C., Skjelbred, P., Skoglund, L.A. and \u00d8ye, I. (1995) Effect of ketamine, and NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain 2694, 1\u20136.","DOI":"10.1016\/0304-3959(94)00170-J"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB42","doi-asserted-by":"crossref","unstructured":"McCabe, M.S., Fowler, R.C., Cadoret, R.J. and Winokur, G. (1972) Symptom differences in schizophrenia with good and poor progosis. Am. J. Psychiatry 128, 1239\u20131243.","DOI":"10.1176\/ajp.128.10.1239"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB43","doi-asserted-by":"crossref","unstructured":"Meltzer, H.Y., Fessler, R.G., Simonovic, M. and Fang, V.S. (1978) Stimulation of rat prolactin secretion by indolealkylamine hallucinogens. Psychopharmacology 56, 255\u2013259.","DOI":"10.1007\/BF00432847"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB44","unstructured":"Meltzer, H.Y., Sturgeon, R.D., Simonovic, M. and Fessler, R.G. (1981) Phencyclidine as an indirect dopamine agonist. In: Domino, E.F. (Ed.), PCP (Phencyclidine): Historical and Current Perspectives. NPP Books, Ann Arbor, pp. 207\u2013242."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB45","doi-asserted-by":"crossref","unstructured":"Nelson, S.R., Howard, R.B., Cross, R.S. and Samson, F. (1980) Ketamine-induced changes in regional glucose utilisation in the rat brain. Anesthesiology 52, 330\u2013334.","DOI":"10.1097\/00000542-198004000-00009"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB46","unstructured":"\u00d8ye, I., Hustveit, O., Maurset, A., Ratti Moberg, E., Paulsen, O. and Skoglund, L.A. (1991) The chiral forms of ketamine as probes for NMDA-receptor function in humans. In: Kameyama, T., Nabeshima, T. and Domino, E.F. (Eds.), NMDA Receptor Related Agents: Biochemistry, Pharmacology and Behavior. NPP Books, Ann Arbor, pp. 381\u2013389."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB47","unstructured":"\u00d8ye, I., Paulsen, O. and Maurset, A. (1992) Effects of ketamine on sensory perception: evidence for a role of N-methyl-d-aspartate receptors. J. Pharmacol. Exp. Ther. 260, 1209\u20131213."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB48","doi-asserted-by":"crossref","unstructured":"Parellada, E., Catafau, A.M., Bernardo, M., Lome\u00f1a, F., Gonz\u00e1lez-Moncl\u00fas, E. and Setoain, J. (1994) Prefrontal dysfunction in young acute neuroleptic-naive schizophrenic patients: a resting and activation SPECT study. Psychiatry Res. Neuroimag. 55, 131\u2013139.","DOI":"10.1016\/0925-4927(94)90021-3"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB49","doi-asserted-by":"crossref","unstructured":"Piercey, M.F., Hoffmann, W.E. and Kaczkofsky, P. (1988) Functional evidence for PCP-like effects of the anti-stroke candidate MK-801. Psychopharmacology (Berlin) 96, 561\u2013562.","DOI":"10.1007\/BF02180042"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB50","doi-asserted-by":"crossref","unstructured":"Piercey, M.F. and Ray, C.A. (1988) Dramatic limbic and cortical effects mediated by high affinity PCP receptors. Life Sci. 43, 379\u2013385.","DOI":"10.1016\/0024-3205(88)90116-6"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB51","doi-asserted-by":"crossref","unstructured":"Rhodes, C.G., Wise, R.J., Gibbs, J.M., Frackowiak, R.S., Hatazawa, J., Palmer, A.j., Thomas, D.G. and Jones, T. (1983) In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas. Ann. Neurol. 14, 614\u2013626.","DOI":"10.1002\/ana.410140604"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB52","doi-asserted-by":"crossref","unstructured":"Scharfetter, C. (1981) Ego-psychopathology: the concept and its empirical evaluation. Psychol. Med. 11, 273\u2013280.","DOI":"10.1017\/S0033291700052090"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB53","doi-asserted-by":"crossref","unstructured":"Scharfetter, C. (1987) Paranoid-halluzinatorische Zustandsbilder bei drogeninduzierten Psychosen. In: Olbrich, H.M. (Ed.), Halluzination und Wahn. Springer-Verlag, Berlin, pp. 42\u201351.","DOI":"10.1007\/978-3-642-93353-0_5"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB54","unstructured":"Scharfetter, C. (1990a) EPP (Ego-Psychopathology). Psychiatric University Hospital Z\u00fcrich, Research Department, Z\u00fcrich."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB55","unstructured":"Scharfetter, C. (1990b) Schizophrene Menschen. Psychologische Verlags Union, Urban and Schwarzenberg, Munich."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB56","unstructured":"Scharfetter, C. (1995) The self-experience of schizophrenics. Empirical studies of the ego\/self in schizophrenia, borderline disorders and depression. Psychiatric University Hospital of Z\u00fcrich, University Press (ISBN 3-9520832-1-6), Z\u00fcrich."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB57","doi-asserted-by":"crossref","unstructured":"Sherman, A.D., Hegwood, T.S., Baruah, S. and Waziri, R. (1991) Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics. Biol. Psychiatry 30, 1191\u20131198.","DOI":"10.1016\/0006-3223(91)90155-F"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB58","doi-asserted-by":"crossref","unstructured":"Simpson, M.D.C., Slater, P., Royston, M.C. and Deakin, J.F.W. (1992) Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Schizophr. Res. 6, 41\u201348.","DOI":"10.1016\/0920-9964(91)90019-N"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB59","unstructured":"Talairach, J. and Tournoux, P. (1988) Co-planar stereotaxic atlas of the human brain. Thieme, Stuttgart."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB60","doi-asserted-by":"crossref","unstructured":"Tamminga, C.A., Tanimoto, K., Kuo, S., Chase, T.N., Contreras, P.C., Rice, K.C., Jackson, A.E. and O'Donohue, T.L. (1987) PCP-induced alterations in cerebral glucose utilization in rat brain: blockade by metaphit, a PCP-receptor-acylating agent. Synapse 1, 497\u2013504.","DOI":"10.1002\/syn.890010514"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB61","doi-asserted-by":"crossref","unstructured":"Volkow, N.D., Brodie, J.D., Wolf, A.P., Angrist, B., Russell, J. and Cancro, R. (1986) Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration. Neurosurg. Psychiatry 49, 1199\u20131202.","DOI":"10.1136\/jnnp.49.10.1199"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB62","unstructured":"Vollenweider, F.X. (1992) Die Anwendung von Psychotomimetika in der Schizophrenieforschung unter besonderer Ber\u00fccksichtigung der Ketamin\/PCP-Modell-Psychose. SUCHT 38, 389\u2013409."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB63","unstructured":"Vollenweider, F.X., Leenders, K.L., Scharfetter, C., Maguire, P., Stadelmann, O. and Angst, J. (1995) Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology (submitted for publication)."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB64","doi-asserted-by":"crossref","unstructured":"Vollenweider, F.X., Leenders, K.L., Scharfetter, C., Antonini, A., Maguire, P., Missimer, J. and Angst, J. (1996) Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglocose (FDG). Eur. Neuropsychopharmacol. (in press).","DOI":"10.1016\/S0924-977X(96)00039-9"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB65","doi-asserted-by":"crossref","unstructured":"Weber, A.C. and Scharfetter, C. (1984) The syndrome concept: history and statistical operationalizations. Psychol. Med. 14, 315\u2013325.","DOI":"10.1017\/S0033291700003585"},{"key":"10.1016\/S0924-977X(96)00042-9_BIB66","unstructured":"Weissman, A.D., Su, T.P., Hedreen, J.C. and London, E.D. (1988) Sigma receptor in post-mortem human brains. J. Pharmacol. Exp. Ther. 247, 29\u201333."},{"key":"10.1016\/S0924-977X(96)00042-9_BIB67","doi-asserted-by":"crossref","unstructured":"Zeilhofer, H.U., Swandulla, D., Geisslinger, G. and Brune, K. (1992) Differential effects of ketamine enantiomeres on NMDA receptor currents in cultured neurons. Eur. J. Pharmacol. 213, 155\u2013158.","DOI":"10.1016\/0014-2999(92)90248-3"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X96000429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X96000429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T18:19:19Z","timestamp":1579025959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X96000429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,2]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,2]]}},"alternative-id":["S0924977X96000429"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(96)00042-9","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[1997,2]]}}}